Oral prostaglandin E2 for the management of ductus dependent congenital heart diseases. Is there a role for home therapy?
Schlesinger
Y
Y
Department of Neonatology, Shaare Zedek Medical Center, Israel.
Schimmel
M S
MS
Eidelman
A I
AI
Glaser
Y
Y
D015232:Dinoprostone / Q000008:administration & dosage*; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male
D015232:Dinoprostone